Wellgistics Health’s (WGRX) “Sell (E)” Rating Reiterated at Weiss Ratings

Weiss Ratings restated their sell (e) rating on shares of Wellgistics Health (NASDAQ:WGRX) in a research report released on Friday,Weiss Ratings reports.

Separately, Wall Street Zen cut shares of Wellgistics Health from a “hold” rating to a “sell” rating in a report on Saturday, September 13th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Wellgistics Health Stock Up 185.4%

Shares of WGRX opened at $1.15 on Friday. Wellgistics Health has a twelve month low of $0.34 and a twelve month high of $7.04. The company has a market capitalization of $103.06 million and a PE ratio of -1.58. The company has a debt-to-equity ratio of 11.16, a quick ratio of 0.11 and a current ratio of 0.32. The firm’s 50-day moving average is $1.03.

Wellgistics Health (NASDAQ:WGRX) last issued its quarterly earnings data on Tuesday, August 19th. The company reported ($0.11) EPS for the quarter. The company had revenue of $7.79 million for the quarter.

Institutional Trading of Wellgistics Health

An institutional investor recently bought a new position in Wellgistics Health stock. ORG Wealth Partners LLC bought a new position in Wellgistics Health, Inc. (NASDAQ:WGRX) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 100,000 shares of the company’s stock, valued at approximately $89,000. ORG Wealth Partners LLC owned approximately 0.11% of Wellgistics Health as of its most recent filing with the Securities & Exchange Commission.

About Wellgistics Health

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.